Dipeptidyl peptidase-4 inhibitors and the ischemic heart: Additional benefits beyond glycemic control
© 2015 Elsevier Ireland Ltd. All rights reserved. Obese-insulin resistance and type 2 diabetes mellitus (T2DM) have become global health problems, and they are both associated with a higher risk of ischemic heart disease. Although reperfusion therapy is the treatment to increase blood supply to the...
Saved in:
Main Authors: | Chattipakorn N., Apaijai N., Chattipakorn S. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84960117199&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42249 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Dipeptidyl peptidase-4 inhibitors and the ischemic heart: Additional benefits beyond glycemic control
by: Nipon Chattipakorn, et al.
Published: (2018) -
Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
by: Apaijai N., et al.
Published: (2017) -
Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
by: Nattayaporn Apaijai, et al.
Published: (2018) -
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
by: Chinda K., et al.
Published: (2014) -
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
by: Chinda K., et al.
Published: (2014)